期刊文献+

阿立哌唑治疗利培酮所致高催乳素血症女性患者的量效关系 被引量:7

Dose-effect relationship of aripiprazole on hyperprolactinemia induced by risperidone in female patients
原文传递
导出
摘要 目的:评估不同剂量阿立哌唑治疗利培酮所致女性精神分裂症患者高催乳素血症的疗效及安全性。方法:61例利培酮所致高催乳素血症女性精神分裂症患者,随机分至阿立哌唑5 mg组(n=16)、10 mg组(n=15)、20 mg组(n=15)和安慰剂组(n=15),维持原有利培酮剂量不变,随访8周。于基线及第2,4和8周末检测血清催乳素(PRL)水平,于基线及8周末评定阳性和阴性症状量表(PANSS)、Barnes静坐不能评定量表(BAS)、Simpson-Angus量表(SAS)及UKU副作用评定量表(UKU)。结果:第8周末,各阿立哌唑剂量组PRL水平均较治疗前显著下降(P<0.01),而安慰剂组治疗前后PRL水平无统计学差异。第8周末,阿立哌唑10 mg组和20 mg组PRL下降率、正常率均显著高于阿立哌唑5 mg组和安慰剂组(P<0.01),而阿立哌唑10 mg组与20 mg组之间无统计学显著差异。研究终点,4组PANSS,CGI-S,SAS和BAS评分及不良反应发生率均无显著性差异。结论:阿立哌唑可有效治疗利培酮所致女性精神分裂症患者的高催乳素血症,最佳治疗剂量为10 mg·d-1。 Objective: To evaluate the efficacy and safety of different doses of aripiprazole on hyperprolactinemia caused by risperidone in female patients with schizophrenia. Methods: Sixty-one female schizophrenic patients with hyperprolactinemia induced by risperidone were randomly divided into aripiprazole 5 mg group( n =16),10 mg group( n = 15),20 mg group( n = 15) and placebo group( n = 15) added on to fixed dose risperidone treatment for 8 weeks. Serum prolactin levels( PRL) were measured at baseline,2,4 and 8 weeks. The Positive and Negative Syndrome Scale( PANSS),the Barnes Akathisia Scale( BAS),Simpson Angus Scale( SAS) and the UKU Side Effects Rating Scale( UKU) were assessed at baseline and week 8. Results: PRL levels in the three aripiprazole groups were significantly reduced at the end of the study compared with the baseline( P〈0. 01),while there was no significant difference between pre- and post-treatment in the placebo group. At week 8,the decline rate and the normal ratio of PRL levels were significantly higher in the 10 mg and 20 mg groups than those in the5 mg and placebo groups( P〈0. 01),but no significant difference was observed between the 10 mg and 20 mg groups. The PANSS,SAS and BAS scores and the incidence of side effects did not differ among all the treatment groups at the end point. Conclusion: Aripiprazole may be effective for treating risperidone-induced hyperprolactinemiain female patients with schizophrenia,and the optimum dose for aripiprazole appears to be 10 mg·d^- 1.
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第5期569-573,共5页 Chinese Journal of New Drugs
基金 优秀人才基金(2009D003014000001) 北京市医管局重点医学专业发展计划(ZYLX201409) 北京市科技计划项目(D121100005012005)
关键词 阿立哌唑 利培酮 高催乳素血症 精神分裂症 量效关系 aripiprazole risperidone hyperprolactinemia schizophrenia dose-effect relationship
  • 相关文献

参考文献15

  • 1INDER W J, CASTLE D. Antipsychotic-induced hyperprolacti- naemia[ J ]. Aust N Z J Psychiatry, 2011,45 (10) :830 - 837.
  • 2CHEN JX, SU YA, BIAN QT, et al. Arlpiprazole treatment of risperidone-induced hyperprolactinemia [ J ]. J Clin Psychiat, 2009, 70(7) : 1058 - 1059.
  • 3陈景旭,张荣珍,李伟,刘艳红,姜丽艳,卞清涛,王绍礼,杨甫德.阿立哌唑治疗利培酮所致高催乳素血症的双盲对照研究[J].中国新药杂志,2014,23(7):811-814. 被引量:16
  • 4ZHAO J, SONG X, AI X,et al. Adjunctive aripiprazole treat- ment for risperidone-induced hyperprolactinemia: an 8-week randomized, open-label, comparative clinical trial[ J ]. PLoS One, 2015,10(10) : e0139717.
  • 5RANJBAR F, SADEGHI-BAZARGANI H, NIARI KHAMS P, et al. Adjunctive treatment with aripiprazole for risperidone-in- duced hyperprolactinemia [ J ]. Neuropsychiatr Dis Treat, 2015, 11:549 -555.
  • 6CHEN JX, SU YA, QING TB, et al. Adjunctive aripiprazole in the treatment ofrisperidone-induced hyperprolactinemia: a ran- domized, double-blind, placebo-controlled, dose-response study I J]- Psychoneuroendocrinology, 2015, 58 : 130 - 140.
  • 7SUZUKI Y, FUKUI N, WATANABE J, et al. Gender differ- ences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients[ J]. Prog Neu- ropsychopharmacol Biol Psychiatry, 2010, 34 ( 7 ) : 1266 - 1268.
  • 8NAGAI G, MIHARA K, NAKAMURA A. Prulactin concentra- tions during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia [ J ]. Psychiatry Clin Neurosci, 2012,66 ( 6 ) : 518 -524.
  • 9苏允爱,司天梅,舒良.抗精神病药与高催乳素血症[J].国外医学(精神病学分册),2003,30(3):160-163. 被引量:58
  • 10KESSLER RM. Aripiprazole: what is the role of dopamine D2 re- ceptor partial agonism? [ J ]. Am J Psychiatry, 2007, 164 (9) : 1310 -1312.

二级参考文献51

  • 1喻东山,余琳.精神药物和高催乳素血症[J].中国新药与临床杂志,2004,23(12):893-896. 被引量:44
  • 2徐乐平,纪菊英,施辉,瞿发林,张斌,邵亚琴,孙剑.阿立哌唑治疗抗精神病药物所致高催乳素血症对照研究[J].中国行为医学科学,2006,15(8):718-720. 被引量:51
  • 3吴文源.临床疗效总评量表(CGI)[M].∥张明圆.精神科评定量表手册.长沙:湖南科学技术出版社,1993,151-154.
  • 4Petty, RG: Schizophrenia Research, 1999, 35: 67-73.
  • 5M. Dhyanne Warner, et al : Psychiatry Research, 2001102: 249-254.
  • 6Dickson RA, Glazer WM: Schizophrenia Research, 1999;35 : 75-86.
  • 7Angelika Wieck: British Medical Journal, 2002; 324: 250-252.
  • 8Sheng-Nan Wu, et al : Neuropsychopharmacology, 2000.23 (6): 676-688.
  • 9Dickson RA, et al: J Clin Psychiatry, 2000, 61 (suppl 3) : 10-14.
  • 10Yasuhiro Kaneda, Akira Fujii: Prog NeuroPsychopharmacol , Biol Psychiat. 2000; 24: 251-258.

共引文献109

同被引文献53

引证文献7

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部